Generic Drug Analysis & Statistics, April 2015 (p20)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

571-600 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

Sitagliptin  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Sitagliptin - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Zolmitriptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Zolmitriptan - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Telmisartan  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Telmisartan - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Ramelteon  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Ramelteon - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Perampanel  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Perampanel - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Rasagiline  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Rasagiline - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Nilotinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Nilotinib - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Milnacipran  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Milnacipran - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Alfuzosin  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Alfuzosin - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Raltegravir  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Raltegravir - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Almotriptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Almotriptan - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Tolterodine  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Tolterodine - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Axitinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Axitinib - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Lapatinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Lapatinib - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Dabrafenib  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Dabrafenib - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Quetiapine  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Quetiapine - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug, Pathology
Simoctocog Alfa  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Simoctocog Alfa - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Fosaprepitant  - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

Fosaprepitant - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

  • $ 1 400
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Ticagrelor  - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

Ticagrelor - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

  • $ 1 400
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Aprepitant  - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

Aprepitant - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

  • $ 1 400
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Tolvaptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

Tolvaptan - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

  • $ 1 400
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Enzalutamide  - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

Enzalutamide - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

  • $ 1 400
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Paliperidone  - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

Paliperidone - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

  • $ 1 400
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Simeprevir  - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

Simeprevir - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

  • $ 1 400
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Elvitegravir  - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

Elvitegravir - Patent, Extension and Data Exclusivity Expiry Snapshot (Fifty countries)

  • $ 1 400
  • Company report
  • April 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

  • Industries : Generic Drug
Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists -Pipeline Insights, 2015

Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Calcitonin Gene-Related ...

  • Industries : Generic Drug
Fumarate De Formoterol-Drug Insights, 2015

Fumarate De Formoterol-Drug Insights, 2015

  • $ 1 000
  • Industry report
  • April 2015
  • by Delve Insight

SUMMARY DelveInsight’s pharmaceuticals report, “Fumarate De Formoterol- Drug Insights, 2015” highlights the Fumarate De Formoterol marketed details and the Global API Manufacturers details across ...

  • Industries : Generic Drug
  • Countries : World, United States, Europe
The 2016-2021 World Outlook for Generic Drugs

The 2016-2021 World Outlook for Generic Drugs

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for generic drugs across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...

  • Industries : Generic Drug
The 2016-2021 World Outlook for Generic Prescription Drugs

The 2016-2021 World Outlook for Generic Prescription Drugs

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for generic prescription drugs across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ...

  • Industries : Generic Drug
The 2016-2021 World Outlook for Over-The-Counter Generic Drugs

The 2016-2021 World Outlook for Over-The-Counter Generic Drugs

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for over-the-counter generic drugs across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Industries : Generic Drug

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.